Sort by
Refine Your Search
-
project on "Targeted covalent Inhibitors against key epigenetic proteins (NMRC)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development of selective and potent
-
under a project on "Targeted covalent Inhibitors against key epigenetic proteins (NMRC)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development of selective and
-
Job Description The successful candidate will work with Prof YAO Shao Qin on chemical biology/drug discovery-related research under a project on "Targeted covalent Inhibitors against key epigenetic
-
Job Description The successful candidate will work with Prof YAO Shao Qin on chemical biology/drug discovery-related research under a project on "Targeted covalent Inhibitors against key epigenetic
-
– Development of Lysine-Targeting, Cell-Active Covalent Inhibitors (CIs) with High Potency and Selectivity (MOE T2)". Human kinases and epigenetic proteins are important therapeutic targets. Recent development
-
epigenetic proteins are important therapeutic targets. Recent development of selective and potent inhibitors of proteins has yielded remarkable results in disease treatment, with numerous drugs already
-
Job Description A Research Fellow position is available to investigate the role of epigenetic modifiers in rhabdomyosarcoma. Qualifications Self-motivated candidates with a recent Ph.D. degree and
-
at least 3 years of work experience in cardiac research Demonstrated knowledge, skills, and expertise in supporting various research activities including bioinformatics, epigenetics, genomics, and proteomics
-
sets, including epigenetics, proteomics, lipidomics Report findings in international peer reviewed journals and relevant information to the general public Presentation of data internally and externally